Skip to main content
. 2019 Jan 8;2019(1):CD006404. doi: 10.1002/14651858.CD006404.pub3

4.9. Analysis.

Comparison 4 Pyronaridine‐artesunate versus other antimalarials for all malaria subtypes (safety outcomes only), Outcome 9 Sensitivity analysis: first treatment, ALT increase > 5 × ULN.